Weekday Japan business intelligence for finance professionals.

Join the list
Tokyo Brief東 京 ブ リ ー フ

Japan's day, wrapped and delivered by morning.

Article

Bplats seeks up to ¥746,097,710 in resettable warrants, with related directors recusing themselves

Bplats plans to allot 20,051 seventh stock acquisition rights to a fund managed by Growth Partners, with a headline gross raise of ¥746,097,710 and a fixed cap of 2,005,100 new shares. Only ¥2,205,610 is paid at issuance, while the exercise price starts at ¥371 and can reset from June 16 to 90% of the previous day's close, subject to a ¥164 floor. The dilution ceiling is clear enough, but the cash haul depends on investors actually exercising. Bplats is trying to fund a balance sheet that already looks strained: it says it booked a ¥767,298,000 software impairment, a ¥925,575,000 net loss and negative net assets at the end of March 2026. Net proceeds are earmarked at ¥552 million for operating funds and ¥186 million for debt repayment, while a bondholder that had gained an early-redemption right after a covenant breach agreed not to use it. Two directors recused themselves from the board vote because one is a lender due to be repaid and another runs the manager tied to the allottee fund. Bplats has bought itself time and a backer. Whether it gets the full money now depends on the market.

May 29, 20264 min read
Boardroom papers showing a warrant financing and loan documents in a corporate office setting

Bplats is trying to repair its balance sheet with a financing that looks large on paper, but arrives only if investors keep exercising. The company plans a third-party allotment of 20,051 seventh stock acquisition rights, effectively warrants, to a fund managed by Growth Partners. If all are exercised, the package could bring in ¥746,097,710 and create 2,005,100 shares. But only ¥2,205,610 is paid at issuance, with the rest dependent on later exercise after the allotment date of June 15.

A headline sum with a big asterisk

The exercise window runs from June 16, 2026 to June 15, 2030. The initial exercise price is ¥371, but from June 16 it can reset to 90% of the previous trading day’s close, rounded up to the nearest yen, with a floor of ¥164. The important tradeoff is that the maximum share count is fixed at 2,005,100 shares, while the eventual cash proceeds are not. They can rise or fall as the reset price moves, and they can fall further if some rights are never exercised or are cancelled.

That structure helps explain why this is more than a routine capital raise. Bplats says it booked a ¥767,298,000 impairment of software assets, recorded a ¥925,575,000 net loss, and fell into negative net assets as of the end of March 2026. An earlier sixth warrant issue to the same Growth Partners-managed fund had raised ¥185 million by the end of March after 4,300 of 13,888 rights were exercised, but the company says progress later stalled because its share price traded below that instrument’s exercise price. It also says new borrowing and refinancing from financial institutions have become difficult, making a faster capital solution more urgent.

Where the money is supposed to go

Bplats estimates net proceeds of ¥738,497,710 after ¥7,600,000 of issuance costs. It plans to use ¥552 million for working capital to support stable operation of the existing business through June 2030, and ¥186 million to repay existing borrowings through September 2028. The company says the operating portion is needed to keep investing in product development and service quality for its Bplats platform, even as it shifts software development and testing toward AI-driven processes.

Another disclosure published the same day makes the funding need look less theoretical. Bplats said the holder of its first unsecured convertible bond with stock acquisition rights had obtained the right to demand early redemption after a financial covenant was triggered, specifically because year-end net assets fell below 75% of the prior year’s level. The holder, the same fund named in the warrant deal, agreed not to exercise that early redemption right, according to the company.

Why the recusals matter

The governance angle is unusually explicit. The chief executive did not take part in the board’s discussion or vote on the warrant allotment because some of the proceeds will be used to repay borrowings for which he is a lender, and the company said he could be viewed as having a special interest in the transaction. Another director also stayed out of the discussion and vote because he is president of Growth Partners, the manager tied to the allottee fund, and the company said he had a special interest as well.

That does not, by itself, make the financing improper. It does show that the raise is tightly bound up with existing financing relationships, not an anonymous market tap. Bplats also says the underwriting agreement is set to require board approval for any transfer of the new rights, a term intended to stop the warrants from being passed on to an unexpected holder without the company’s consent.

For investors, the cleanest reading is this: Bplats has found a backer willing to keep funding a restructuring story, and to waive an immediate pressure point on an older instrument, but the company is still relying on future exercises for most of the money to arrive. The maximum share issuance is capped at 2,005,100 shares. The final cash haul is not. That is the core balance between financing flexibility and dilution risk in this deal, and it is why the boardroom conflicts deserved almost as much disclosure space as the headline funding number.